comparemela.com

Latest Breaking News On - Nanometrix ltd - Page 1 : comparemela.com

NurExone Biologic Inc : NurExone Issues Annual Shareholder Letter

Calgary, Alberta (Newsfile Corp. - December 15, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) ("we", "our", the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided

Israel generalUnited statesUnited kingdomLior shaltielLyora aharonovShulamit levenbergCompany or nurexoneDean of the biomedical engineering departmentNurexone biologic incAlberta newsfile corpVenture exchangeRegulation services providerDrug administrationYissum research development companyNanometrix ltdIsrael institute of technology

2022-12-15 | TSXV:NRX | Press Release | NurExone Biologic Inc

(2022-12-15 | TSXV:NRX) NurExone Issues Annual Shareholder Letter

Israel generalUnited statesUnited kingdomLior shaltielLyora aharonovShulamit levenbergCompany or nurexoneDean of the biomedical engineering departmentNurexone biologic incAlberta newsfile corpVenture exchangeRegulation services providerDrug administrationYissum research development companyNanometrix ltdIsrael institute of technology

2022-11-24 | TSXV:NRX | Press Release | NurExone Biologic Inc

(2022-11-24 | TSXV:NRX) NurExone Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Israel generalUnited statesHebrew universityJames jay richardsonLior shaltielNurexone exotherapyBurstyn cohen labCompany or nurexoneCompany onEnerspar corpNurexone biologic incCompany exotherapyAlberta newsfile corpYissum research development companyDrug administrationNanometrix ltd

NurExone Biologic Inc : NurExone Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Calgary, Alberta (Newsfile Corp. - November 24, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (the "Company" or "NurExone"), a biopharmaceutical company developing biologically-guided exosome

Israel generalUnited statesHebrew universityJames jay richardsonLior shaltielNurexone exotherapyBurstyn cohen labCompany or nurexoneCompany onEnerspar corpNurexone biologic incCompany exotherapyAlberta newsfile corpVenture exchangeRegulation services providerYissum research development company

vimarsana © 2020. All Rights Reserved.